Key result
Blood and CSF fibrinopeptide A levels were significantly raised after SAH versus controls, with CSF FPA correlating with 3-month clinical outcome, though not with angiographic vasospasm.
Case-Control
Answers are grounded in this paper and cite their sources.
Reveals elevated blood and CSF fibrinopeptide A following subarachnoid hemorrhage, indicating thrombin activity correlates with initial bleeding volume and long-term recovery.
Fibrinopeptide A (FPA) levels which have been shown to be a quantitative index of thrombin generation, were measured in blood and cerebrospinal fluid (CSF) samples from patients following subarachnoid haemorrhage (SAH) and from a control population. The levels found in samples obtained in patients following SAH are compared with those found in controls and also correlated with clinical grade on admission as assessed by the Glasgow Coma Score and the World Federation of Neurological Surgeons' grading system, and with the amount of subarachnoid blood seen on CT, the occurrence of ischaemic deterioration, the occurrence of low-density change on CT, the presence of vasospasm on angiography, clinical outcome as assessed by the Glasgow Outcome Score 3 months following the ictus, and the incidence of ischaemia as a cause of death or disability as assessed 3 months following the ictus. The levels of FPA found in blood and CSF from patients following SAH were significantly raised when compared with those found in controls. There was significant correlation between blood FPA levels and the amount of subarachnoid blood seen on initial CT. CSF FPA levels had a statistically significant correlation with outcome as assessed at 3 months post-ictus. No statistically significant correlation was found between blood or CSF FPA levels and any of the other variables studied.
No takes yet. Share an insight, caveat, or question.
O’Neill et al. (1992) conducted a case-control in Aneurysmal subarachnoid haemorrhage (SAH) and cerebral vasospasm. Blood and CSF fibrinopeptide A (FPA) levels (thrombin generation) vs. Control population was evaluated on Correlation of blood and CSF FPA levels with subarachnoid blood on CT, angiographic vasospasm, ischaemic deterioration, and clinical outcome at 3 months. Blood and CSF fibrinopeptide A levels were significantly raised after SAH versus controls, with CSF FPA correlating with 3-month clinical outcome, though not with angiographic vasospasm.
Synapse has enriched 10 related papers. Consider them for comparative context: